Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Lilly Icos continues to develop PDE5 inhibitors

June 27, 2002

Recent patent covers new PDE5 inhibitors designed at Lilly Icos

June 21, 2002

Trospium completes phase III trial in overactive bladder

June 20, 2002

Senju patents novel Na+/Ca2+ exchange inhibitors

June 19, 2002

Boehringer Ingelheim claims new agents for urinary incontinence

June 18, 2002

Shire files for approval of Fosrenol in Canada

June 11, 2002

Nasal apomorphine set to enter phase I trials for erectile dysfunction

June 7, 2002

IPD-1151T may be preferable to other drugs in the treatment of interstitial cystitis

June 6, 2002

A possible role for the nicotinic agonist epibatidine in neurogenic voiding dysfunction

June 6, 2002

KW-7158 depresses bladder hyperactivity through afferent pathways

June 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...